Nathan Trading Co., Ltd.
⚠️ High Risk
FEI: 3012099156 • Khemarat, Ubon Ratchathani • THAILAND
FEI Number
3012099156
Location
Khemarat, Ubon Ratchathani
Country
THAILANDAddress
Moo 12, 58 Palan Sub-District, Khemarat, Ubon Ratchathani, Thailand
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 2/22/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | 508NO 510(K) | Division of West Coast Imports (DWCI) |
| 2/22/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | 508NO 510(K) | Division of West Coast Imports (DWCI) |
| 2/22/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | 508NO 510(K) | Division of West Coast Imports (DWCI) |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | 508NO 510(K) | Division of West Coast Imports (DWCI) |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 1/23/2023 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 10/19/2022 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 10/19/2022 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 10/19/2022 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 10/19/2022 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) | |
| 10/19/2022 | 80LZAGLOVE, PATIENT EXAMINATION, POLY | Division of West Coast Imports (DWCI) |
Frequently Asked Questions
What is Nathan Trading Co., Ltd.'s FDA import refusal history?
Nathan Trading Co., Ltd. (FEI: 3012099156) has 15 FDA import refusal record(s) in our database, spanning from 10/19/2022 to 2/22/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Nathan Trading Co., Ltd.'s FEI number is 3012099156.
What types of violations has Nathan Trading Co., Ltd. received?
Nathan Trading Co., Ltd. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Nathan Trading Co., Ltd. come from?
All FDA import refusal data for Nathan Trading Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.